Diseases /

Endometrioid Adenocarcinoma

Back to Diseases List
Associated Genetic Biomarkers

Overview

NCI Definition: An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament. [1]

Clinical Trials

View Clinical Trials for Endometrioid Adenocarcinoma

Significant Genes in Endometrioid Adenocarcinoma

FGFR2 +

MLH1 +

MSH2 +

MSH6 +

PMS2 +

Disease Details

Synonyms
Endometrioid Carcinoma of Female Reproductive System, Endometrioid Carcinoma of the Female Reproductive System, Endometrioid Carcinoma, Female Reproductive Endometrioid Carcinoma
Parent(s)
Malignant Female Reproductive System Neoplasm
Children
Vaginal Endometrioid Adenocarcinoma, Primary Peritoneal Endometrioid Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Uterine Ligament Endometrioid Adenocarcinoma, Cervical Endometrioid Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, and Endometrioid Adenocarcinoma, Variant with Squamous Differentiation

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.